Home » Healthcare » UAE Over-the-Counter (OTC) Pharmaceuticals Market

UAE Over-the-Counter (OTC) Pharmaceuticals Market By Product Categories (Pain Relievers and Fever Reducers, Cough and Cold Medications, Gastrointestinal Medications, Vitamins and Dietary Supplements, Skin Care and Dermatological Products, Weight Loss and Nutritional Products, Allergy Medications, Sleep Aids, Oral Care Products, Eye Care Products, Ear Care Products, First Aid Supplies) By Distribution Channels (Pharmacies and Drugstores, Supermarkets and Hypermarkets, Online Retail, Convenience Stores, Specialty Health Stores) By End Users (Adults, Pediatric OTC, Geriatric OTC, Sports and Fitness OTC) – Growth, Future Prospects & Competitive Analysis, 2022 – 2030

Summary
Table Of Content

Market Insights

The UAE demand for over-the-counter (OTC) pharmaceuticals was valued at USD 0.61 million in 2022 and is expected to reach USD 0.87 million in 2030, growing at a CAGR of 4.60% between 2023 and 2030.
Cough and cold medications are the leading segment by product categories. Pain relievers and fever reducers, on the other hand, are expected to grow at a strong CAGR.
The leading distribution channels segment is pharmacies and drugstores.
The CAGR for pediatric OTC is expected to be the highest during the projection period.

Increasing advancements in genetic research, the rise of personalized medicine, and cost-effectiveness and efficiency are the key factors boosting the UAE over-the-counter (OTC) pharmaceuticals market.
Due to the growing senior population, cutting-edge drug delivery technologies, and emphasis on over-the-counter (OTC) allergy treatments, the UAE over-the-counter (OTC) pharmaceutical industry has plenty of opportunities to grow.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Executive Summary

Market Definition

The non-prescription pharmaceutical and healthcare product industry directly accessible to consumers without a prescription is the over-the-counter (OTC) pharmaceuticals market in the United Arab Emirates. It covers many goods, such as vitamins, skincare products, cough and cold medicines, and pain relievers. Accessibility, which enables customers to buy these items without a prescription from a medical practitioner, distinguishes this industry and helps people care for themselves and their health in the United Arab Emirates.

Market Overview

The UAE over-the-counter (OTC) pharmaceutical market has expanded steadily in recent years. Between 2023 and 2030, it is anticipated to rise at a CAGR of 4.60%. The market was estimated to be worth USD 0.61 million in 2022, and it is anticipated to be worth USD 0.87 million in 2030.

Senior citizens and the aged population are growing rapidly. An additional 1.5 billion individuals will be 65 years of age or older by 2050, according to World Health Organisation (WHO) projections. Developing countries like China, Japan, India, and South Korea are expected to see a rise in this figure. Diabetes, blood pressure, cancer, and blood sugar levels are among the health problems that older people face. Improved health care must be given to them. Patients, therefore, need to take their drugs at certain times. Some older adults buy prescription drugs without a prescription on occasion. The growing geriatric population is driving the anticipated growth of the UAE over-the-counter (OTC) pharmaceuticals market.

Furthermore, consumption habits have changed due to the coronavirus outbreak. This has created fresh growth potential for the market for these medications. Before approximately ten years ago, people had no idea what causes the typical cold and cough. However, people have come to understand the value of good health in the wake of the pandemic. Many consumers know which medications can be used to treat specific health issues. The increased awareness of general health issues is predicted to propel the UAE over-the-counter (OTC) pharmaceuticals market higher over the forecast period.

Customers in the UAE are becoming more proactive in maintaining their health and well-being. They can easily care for common health conditions without visiting a doctor using over-the-counter medications. Empowered consumers may seek personalized health solutions, including OTC products tailored to their needs. This can drive innovation in the market, with companies developing products that cater to individual preferences and health goals.

Segmentation by Product Categories

Cough and cold medications are the market leader by product categories. Cough medications often contain dextromethorphan or codeine, which help suppress coughing. These medications are used to alleviate dry, irritating coughs. Various substances are combined in cold medication to treat symptoms like runny nose, nasal congestion, and sneezing. To alleviate allergies, antihistamines such as loratadine or diphenhydramine may be added.
The pain relievers and fever reducers category is anticipated to exhibit a sizable CAGR during the projected period. Pain relievers such as acetaminophen (paracetamol), ibuprofen, and aspirin are commonly used to alleviate headaches, whether they are tension headaches or related to other causes. Acetaminophen, ibuprofen, and aspirin effectively reduce fever associated with infections, such as colds, flu, or other inflammatory conditions.
Other product categories, such as gastrointestinal medications, vitamins and dietary supplements, skincare and dermatological products, weight loss and nutritional products, allergy medications, sleep aids, oral care products, eye care products, ear care products, and first aid supplies, also contribute to the demand for UAE over the counter (OTC) pharmaceuticals.

Segmentation by Distribution Channels

The main distribution channels category is pharmacies and drugstores. Pharmacists in pharmacies and drugstores play a critical role in providing professional guidance and advice to consumers. They help customers choose the right OTC products based on their symptoms, health conditions, and other factors.
The online retail category will likely register a significant CAGR during forecasting. Online channels provide a level of privacy for consumers purchasing sensitive health products. This can be especially important for individuals seeking remedies for personal health concerns.
Other distribution channels, such as supermarkets and hypermarkets, convenience stores, and speciality health stores, also contribute to the demand for UAE over-the-counter (OTC) pharmaceuticals.

Segmentation by End Users

The pediatric OTC category is anticipated to experience the highest CAGR during the projection period. Healthcare professionals, especially paediatricians, are crucial in guiding parents and caregivers in selecting and using OTC medications for children. They provide recommendations based on the child’s age, weight, and specific health conditions.
Other end users, such as adults, geriatric OTC, and sports and fitness OTC, also contribute to the demand for UAE over-the-counter (OTC) pharmaceuticals.

The over-the-counter (OTC) pharmaceuticals market in the United Arab Emirates might be significantly driven by pharmacy accessibility. Due to the UAE’s extensive pharmacy network, OTC medications are easily accessible to customers in various geographical areas. Improved pharmacy accessibility means more points of sale for OTC pharmaceuticals, making these products readily available to a larger population. This can drive sales and increase consumer exposure to OTC options. Quick access to pharmacies allows consumers to promptly address minor health issues and manage symptoms with OTC medications. This immediacy can be a driving force behind the preference for OTC solutions.

The country’s ageing population may significantly influence the UAE’s over-the-counter (OTC) pharmaceuticals market. The incidence of health issues continues to increase with age. For the treatment of age-related health issues, chronic illness management, and pain management, the older population may need over-the-counter medications. Age-related conditions, such as arthritis, may lead to chronic pain. OTC pain relievers can be in demand among older people for managing daily discomfort without the need for frequent medical consultations.

Key Highlights of the Report

The UAE over-the-counter (OTC) pharmaceuticals market is segmented by product categories, distribution channels, and end users. Regarding the product categories, cough and cold medications are the market spearheads. Pharmacies and drugstores are the top distribution channels segment. The pediatric OTC category is expected to grow at the highest CAGR during the forecast period.

The over-the-counter (OTC) pharmaceuticals market is expected to grow substantially due to the UAE’s growing healthcare infrastructure. Demand for over-the-counter drugs is rising in tandem with the growing emphasis on improved medical facilities and accessibility to healthcare. In addition to facilitating simpler distribution routes, the expanding infrastructure also promotes increased consumer knowledge and self-care behaviours, which propels the OTC pharmaceuticals market as a crucial part of the changing healthcare industry in the United Arab Emirates.

Technological advancements are expected to significantly influence the UAE’s over-the-counter (OTC) pharmaceuticals market expansion. Mobile health monitoring, medication reminders, and wellness tracking applications can complement OTC pharmaceuticals. These apps enhance consumer engagement and adherence to self-care regimens. Technological advancements also enable virtual healthcare consultations, allowing consumers to seek advice and recommendations for OTC products remotely. This accessibility can drive the adoption of OTC solutions.

Which Key Factors Are Driving The UAE Over-the-counter (OTC) Pharmaceuticals Market?

The rising prevalence of chronic diseases, growing elderly population, increasing awareness of self-care, and expanding healthcare infrastructure are driving the expansion of the over-the-counter (OTC) pharmaceuticals market in the United Arab Emirates.

What Are The Key Challenges In The UAE Market For Over the Counter (OTC) Pharmaceuticals?

Several challenges, including high competition, stringent regulatory framework, limited consumer awareness and cultural and religious factors, impede the growth of the UAE over-the-counter (OTC) pharmaceuticals market.

What Market Opportunities Exist For UAE Over-The-Counter (OTC) Pharmaceuticals?

Increasing health consciousness, digital health integration, e-commerce growth, and innovative product development create significant opportunities for the UAE over-the-counter (OTC) pharmaceuticals market.

Market Drivers

Several factors influence the market for UAE over-the-counter (OTC) pharmaceuticals. The main factors influencing the market for UAE over-the-counter (OTC) pharmaceuticals are as follows:

Rising Prevalence of Chronic Diseases

The growing incidence of chronic diseases may significantly influence the over-the-counter (OTC) pharmaceuticals market in the United Arab Emirates. Individuals with chronic diseases often experience symptoms that can be managed with OTC medications. The growing number of people living with chronic conditions can drive the demand for over-the-counter products that address specific symptoms. As chronic diseases may require ongoing management, individuals might seek convenient and accessible solutions for their day-to-day healthcare needs. OTC medications offer a self-care option for managing common symptoms without the need for frequent visits to healthcare professionals. OTC pharmaceuticals often include products that support preventive care, such as vitamins and supplements. People with chronic diseases may be more inclined to use OTC products as a proactive measure to support their overall health.

Market Restraints

Several challenges could prevent the expansion of the UAE market for over-the-counter (OTC) pharmaceuticals. Among them are the following:

Variant Interpretation Challenges

Integrating variant interpretation into existing healthcare systems, especially in the OTC context, can be challenging. This includes linking genetic information to over-the-counter pharmaceutical recommendations effectively. Understanding and interpreting genetic variants requires a certain level of education and awareness among healthcare professionals and consumers. Knowledge in this area is needed to implement personalized medicine solutions. Variant interpretation technologies and personalized medicine can be costly. Affordability and cost-effectiveness influence market accessibility and adoption, especially in OTC. The availability of diverse genetic data is crucial for accurate variant interpretation. More than limited representation of certain populations in genetic databases can result in challenges for personalized medicine implementation.

Opportunities

The UAE market for over-the-counter (OTC) pharmaceuticals presents significant potential opportunities. The following is an example of these:

Expanding Digital Health Integration

Integrating digital health technology may drive the over-the-counter (OTC) pharmaceuticals market in the United Arab Emirates. Telehealth platforms can connect consumers with healthcare professionals for consultations and advice. This integration can lead to increased awareness of OTC options and personalized recommendations for self-care. Digital platforms providing reliable health information can educate consumers about OTC products, their uses, and proper dosage. This information can empower consumers to make informed decisions. Digital tools like AI-powered health apps can provide personalized health recommendations based on individual health data. This integration enhances the effectiveness of OTC pharmaceuticals by tailoring suggestions to specific consumer needs. Integrating virtual consultations with pharmacists or healthcare professionals can enhance the customer experience. Consumers can seek advice on OTC products, improving their understanding and confidence in self-medication.

Competitive Landscape

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Players

The UAE market for over-the-counter (OTC) pharmaceuticals is very competitive, with many powerful players. Some of the leading market participants and their corresponding market shares are listed below:

Johnson and Johnson Services Inc (USA)
Bayer AG (Germany)
Novartis AG (Switzerland)
Sanofi (France)
Pfizer (USA)
GlaxoSmithKline Plc (UK)
Boehringer Ingelheim International GmbH (Germany)
Reckitt Benckiser Group Plc (UK)
Takeda Pharmaceuticals (Tokyo)
Others

These companies prioritise mergers and acquisitions, expanding their distribution network, and developing new products to remain competitive.

The leading competitors in the UAE market for over-the-counter (OTC) pharmaceuticals constantly seek an advantage by releasing new products and advancements.

In July 2022, The China Cross Border E-Commerce (CBEC) online platform Tmall Global announced that AFT Pharmaceuticals and RooLife Group have introduced a variety of AFT over-the-counter (OTC) Pharmaceuticals through their store.

In March 2020, GSK announced that the U.S. Food and Drug Administration (FDA) had approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) medication for pain treatment. It is the first ibuprofen and acetaminophen over-the-counter combination approved by the FDA in the United States and will be sold everywhere.

Summary of Key Findings

The UAE over-the-counter (OTC) pharmaceuticals market continues to grow due to the rising prevalence of chronic diseases.
The market is segmented by product categories, distribution channels, and end users.
Cough and cold medications are the most preferred product categories in the market.
Pharmacies and drugstores are the most common in terms of distribution channels.
Regarding CAGR, the pediatric OTC category is expected to grow fastest during the forecast period.
The UAE over-the-counter (OTC) pharmaceuticals market is highly competitive with key players including Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland), Sanofi (France), Pfizer (USA), GlaxoSmithKline Plc (UK), Boehringer Ingelheim International GmbH (Germany), Reckitt Benckiser Group Plc (UK), Takeda Pharmaceuticals (Tokyo), and others.

Future Outlook

Optimistic viewpoint for the over-the-counter (OTC) pharmaceuticals industry with noteworthy growth potential in the UAE.
The rise of personalized medicine is one of the main elements driving the expansion of the over-the-counter (OTC) pharmaceuticals market in the United Arab Emirates.
During the projected period, the difficulties with variant interpretation for UAE over-the-counter (OTC) pharmaceuticals might significantly challenge the market’s expansion.
Foremost companies must concentrate on product innovation, expanding their market reach, and maintaining competitive pricing to stay ahead.

Segmentation

By Product Categories

Pain Relievers and Fever Reducers
Cough and Cold Medications
Gastrointestinal Medications
Vitamins and Dietary Supplements
Skin Care and Dermatological Products
Weight Loss and Nutritional Products
Allergy Medications
Sleep Aids
Oral Care Products
Eye Care Products
Ear Care Products
First Aid Supplies

By Distribution Channels

Pharmacies and Drugstores
Supermarkets and Hypermarkets
Online Retail
Convenience Stores
Specialty Health Stores

By End Users

Adults
Pediatric OTC
Geriatric OTC
Sports and Fitness OTC

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: UAE Over The Counter (OTC) Pharmaceuticals Market
2.1.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Product Categories
2.1.2. UAE Over The Counter (OTC) Pharmaceuticals Market, By Distribution Channels
2.1.3. UAE Over The Counter (OTC) Pharmaceuticals Market, By End Users
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. UAE Over The Counter (OTC) Pharmaceuticals Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Over The Counter (OTC) Pharmaceuticals Market Drivers
3.2.2. Over The Counter (OTC) Pharmaceuticals Market Restraints
3.2.3. Over The Counter (OTC) Pharmaceuticals Market Opportunities
3.2.4. Major Over The Counter (OTC) Pharmaceuticals Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product Categories
3.5.2. Distribution Channels
3.5.3. End Users
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. UAE Over The Counter (OTC) Pharmaceuticals Market: Company Market Share, Value 2022
4.1.2. UAE Over The Counter (OTC) Pharmaceuticals Market: Top 6 Company Market Share, Value 2022
4.1.3. UAE Over The Counter (OTC) Pharmaceuticals Market: Top 3 Company Market Share, Value 2022
4.2. UAE Over The Counter (OTC) Pharmaceuticals Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the UAE Over The Counter (OTC) Pharmaceuticals Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the UAE market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID 19 and Russia – Ukraine War on UAE Over The Counter (OTC) Pharmaceuticals Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Impact Analysis
7.2.5.1. UAE
8. UAE Over The Counter (OTC) Pharmaceuticals Market, By Product Categories
8.1. UAE Over The Counter (OTC) Pharmaceuticals Market Overview, by Product Categories
8.1.1. UAE Over The Counter (OTC) Pharmaceuticals Market Revenue Share, By Product Categories, 2022 Vs 2030 (in %)
8.2. Pain Relievers and Fever Reducers
8.2.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Pain Relievers and Fever Reducers, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Pain Relievers and Fever Reducers
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Cough and Cold Medications
8.3.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Cough and Cold Medications, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Cough and Cold Medications
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Gastrointestinal Medications
8.4.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Gastrointestinal Medications, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for Gastrointestinal Medications
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Vitamins and Dietary Supplements
8.5.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Vitamins and Dietary Supplements, 2017-2030 (US$ Mn)
8.5.2. Market Dynamics for Vitamins and Dietary Supplements
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Skin Care and Dermatological Products
8.6.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Skin Care and Dermatological Products, 2017-2030 (US$ Mn)
8.6.2. Market Dynamics for Skin Care and Dermatological Products
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
8.7. Weight Loss and Nutritional Products
8.7.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Weight Loss and Nutritional Products, 2017-2030 (US$ Mn)
8.7.2. Market Dynamics for Weight Loss and Nutritional Products
8.7.2.1. Drivers
8.7.2.2. Restraints
8.7.2.3. Opportunities
8.7.2.4. Trends
8.8. Allergy Medications
8.8.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Allergy Medications, 2017-2030 (US$ Mn)
8.8.2. Market Dynamics for Allergy Medications
8.8.2.1. Drivers
8.8.2.2. Restraints
8.8.2.3. Opportunities
8.8.2.4. Trends
8.9. Sleep Aids
8.9.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Sleep Aids, 2017-2030 (US$ Mn)
8.9.2. Market Dynamics for Sleep Aids
8.9.2.1. Drivers
8.9.2.2. Restraints
8.9.2.3. Opportunities
8.9.2.4. Trends
8.10. Oral Care Products
8.10.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Oral Care Products, 2017-2030 (US$ Mn)
8.10.2. Market Dynamics for Oral Care Products
8.10.2.1. Drivers
8.10.2.2. Restraints
8.10.2.3. Opportunities
8.10.2.4. Trends
8.11. Eye Care Products
8.11.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Eye Care Products, 2017-2030 (US$ Mn)
8.11.2. Market Dynamics for Eye Care Products
8.11.2.1. Drivers
8.11.2.2. Restraints
8.11.2.3. Opportunities
8.11.2.4. Trends
8.12. Ear Care Products
8.12.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Ear Care Products, 2017-2030 (US$ Mn)
8.12.2. Market Dynamics for Ear Care Products
8.12.2.1. Drivers
8.12.2.2. Restraints
8.12.2.3. Opportunities
8.12.2.4. Trends
8.13. First Aid Supplies
8.13.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By First Aid Supplies, 2017-2030 (US$ Mn)
8.13.2. Market Dynamics for First Aid Supplies
8.13.2.1. Drivers
8.13.2.2. Restraints
8.13.2.3. Opportunities
8.13.2.4. Trends
9. UAE Over The Counter (OTC) Pharmaceuticals Market, By Distribution Channels
9.1. UAE Over The Counter (OTC) Pharmaceuticals Market Overview, by Distribution Channels
9.1.1. UAE Over The Counter (OTC) Pharmaceuticals Market Revenue Share, By Distribution Channels, 2022 Vs 2030 (in %)
9.2. Pharmacies and Drugstores
9.2.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Pharmacies and Drugstores, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Pharmacies and Drugstores
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Supermarkets and Hypermarkets
9.3.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Supermarkets and Hypermarkets, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Supermarkets and Hypermarkets
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Online Retail
9.4.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Online Retail, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Online Retail
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Convenience Stores
9.5.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Convenience Stores, 2017-2030 (US$ Mn)
9.5.2. Market Dynamics for Convenience Stores
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
9.6. Specialty Health Stores
9.6.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Specialty Health Stores, 2017-2030 (US$ Mn)
9.6.2. Market Dynamics for Specialty Health Stores
9.6.2.1. Drivers
9.6.2.2. Restraints
9.6.2.3. Opportunities
9.6.2.4. Trends
10. UAE Over The Counter (OTC) Pharmaceuticals Market, By End Users
10.1. UAE Over The Counter (OTC) Pharmaceuticals Market Overview, by End Users
10.1.1. UAE Over The Counter (OTC) Pharmaceuticals Market Revenue Share, By End Users, 2022 Vs 2030 (in %)
10.2. Adults
10.2.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Adults, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Adults
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Pediatric OTC
10.3.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Pediatric OTC, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Pediatric OTC
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Geriatric OTC
10.4.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Geriatric OTC, 2017-2030 (US$ Mn)
10.4.2. Market Dynamics for Geriatric OTC
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Sports and Fitness OTC
10.5.1. UAE Over The Counter (OTC) Pharmaceuticals Market, By Sports and Fitness OTC, 2017-2030 (US$ Mn)
10.5.2. Market Dynamics for Sports and Fitness OTC
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
11. Company Profiles
11.1. Johnson and Johnson Services Inc. (USA)
11.1.1. Company Overview
11.1.2. Products/Services Portfolio
11.1.3. Geographical Presence
11.1.4. SWOT Analysis
11.1.5. Financial Summary
11.1.5.1. Market Revenue and Net Profit (2019-2022)
11.1.5.2. Business Segment Revenue Analysis
11.1.5.3. Geographical Revenue Analysis
11.2. Bayer AG (Germany)
11.3. Novartis AG (Switzerland)
11.4. Sanofi (France)
11.5. Pfizer (USA)
11.6. GlaxoSmithKline Plc (UK)
11.7. Boehringer Ingelheim International GmbH (Germany)
11.8. Reckitt Benckiser Group Plc (UK)
11.9. Takeda Pharmaceuticals (Tokyo)
11.10. Others
12. Research Methodology
12.1. Research Methodology
12.2. Phase I – Secondary Research
12.3. Phase II – Data Modelling
12.3.1. Company Share Analysis Model
12.3.2. Revenue Based Modelling
12.4. Phase III – Primary Research
12.5. Research Limitations
12.5.1. Assumptions

List of Figures
FIG. 1 UAE Over The Counter (OTC) Pharmaceuticals Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 UAE Over The Counter (OTC) Pharmaceuticals Market Segmentation
FIG. 4 UAE Over The Counter (OTC) Pharmaceuticals Market, by Product Categories, 2022 (US$ Mn)
FIG. 5 UAE Over The Counter (OTC) Pharmaceuticals Market, by Distribution Channels, 2022 (US$ Mn)
FIG. 6 UAE Over The Counter (OTC) Pharmaceuticals Market, by End Users, 2022 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Product Categories, 2022
FIG. 8 Attractive Investment Proposition, by Distribution Channels, 2022
FIG. 9 Attractive Investment Proposition, by End Users, 2022
FIG. 10 UAE Market Share Analysis of Key Over The Counter (OTC) Pharmaceuticals Market Manufacturers, 2022
FIG. 11 UAE Market Positioning of Key Over The Counter (OTC) Pharmaceuticals Market Manufacturers, 2022
FIG. 12 UAE Over The Counter (OTC) Pharmaceuticals Market Value Contribution, By Product Categories, 2022 & 2030 (Value %)
FIG. 13 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pain Relievers and Fever Reducers, Value, 2017-2030 (US$ Mn)
FIG. 14 UAE Over The Counter (OTC) Pharmaceuticals Market, by Cough and Cold Medications, Value, 2017-2030 (US$ Mn)
FIG. 15 UAE Over The Counter (OTC) Pharmaceuticals Market, by Gastrointestinal Medications, Value, 2017-2030 (US$ Mn)
FIG. 16 UAE Over The Counter (OTC) Pharmaceuticals Market, by Vitamins and Dietary Supplements, Value, 2017-2030 (US$ Mn)
FIG. 17 UAE Over The Counter (OTC) Pharmaceuticals Market, by Skin Care and Dermatological Products, Value, 2017-2030 (US$ Mn)
FIG. 18 UAE Over The Counter (OTC) Pharmaceuticals Market, by Weight Loss and Nutritional Products, Value, 2017-2030 (US$ Mn)
FIG. 19 UAE Over The Counter (OTC) Pharmaceuticals Market, by Allergy Medications, Value, 2017-2030 (US$ Mn)
FIG. 20 UAE Over The Counter (OTC) Pharmaceuticals Market, by Sleep Aids, Value, 2017-2030 (US$ Mn)
FIG. 21 UAE Over The Counter (OTC) Pharmaceuticals Market, by Oral Care Products, Value, 2017-2030 (US$ Mn)
FIG. 22 UAE Over The Counter (OTC) Pharmaceuticals Market, by Eye Care Products, Value, 2017-2030 (US$ Mn)
FIG. 23 UAE Over The Counter (OTC) Pharmaceuticals Market, by Ear Care Products, Value, 2017-2030 (US$ Mn)
FIG. 24 UAE Over The Counter (OTC) Pharmaceuticals Market, by First Aid Supplies, Value, 2017-2030 (US$ Mn)
FIG. 25 UAE Over The Counter (OTC) Pharmaceuticals Market Value Contribution, By Distribution Channels, 2022 & 2030 (Value %)
FIG. 26 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pharmacies and Drugstores, Value, 2017-2030 (US$ Mn)
FIG. 27 UAE Over The Counter (OTC) Pharmaceuticals Market, by Supermarkets and Hypermarkets, Value, 2017-2030 (US$ Mn)
FIG. 28 UAE Over The Counter (OTC) Pharmaceuticals Market, by Online Retail, Value, 2017-2030 (US$ Mn)
FIG. 29 UAE Over The Counter (OTC) Pharmaceuticals Market, by Convenience Stores, Value, 2017-2030 (US$ Mn)
FIG. 30 UAE Over The Counter (OTC) Pharmaceuticals Market, by Specialty Health Stores, Value, 2017-2030 (US$ Mn)
FIG. 31 UAE Over The Counter (OTC) Pharmaceuticals Market Value Contribution, By End Users, 2022 & 2030 (Value %)
FIG. 32 UAE Over The Counter (OTC) Pharmaceuticals Market, by Adults, Value, 2017-2030 (US$ Mn)
FIG. 33 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pediatric OTC, Value, 2017-2030 (US$ Mn)
FIG. 34 UAE Over The Counter (OTC) Pharmaceuticals Market, by Geriatric OTC, Value, 2017-2030 (US$ Mn)
FIG. 35 UAE Over The Counter (OTC) Pharmaceuticals Market, by Sports and Fitness OTC, Value, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: UAE Over The Counter (OTC) Pharmaceuticals Market
TABLE 2 UAE Over The Counter (OTC) Pharmaceuticals Market: Market Drivers Impact Analysis
TABLE 3 UAE Over The Counter (OTC) Pharmaceuticals Market: Market Restraints Impact Analysis
TABLE 4 UAE Over The Counter (OTC) Pharmaceuticals Market, by Competitive Benchmarking, 2022
TABLE 5 UAE Over The Counter (OTC) Pharmaceuticals Market, by Geographical Presence Analysis, 2022
TABLE 6 UAE Over The Counter (OTC) Pharmaceuticals Market, by Key Strategies Analysis, 2022
TABLE 7 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pain Relievers and Fever Reducers, 2017-2022 (US$ Mn)
TABLE 8 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pain Relievers and Fever Reducers, 2023-2030 (US$ Mn)
TABLE 9 UAE Over The Counter (OTC) Pharmaceuticals Market, by Cough and Cold Medications, 2017-2022 (US$ Mn)
TABLE 10 UAE Over The Counter (OTC) Pharmaceuticals Market, by Cough and Cold Medications, 2023-2030 (US$ Mn)
TABLE 11 UAE Over The Counter (OTC) Pharmaceuticals Market, by Gastrointestinal Medications, 2017-2022 (US$ Mn)
TABLE 12 UAE Over The Counter (OTC) Pharmaceuticals Market, by Gastrointestinal Medications, 2023-2030 (US$ Mn)
TABLE 13 UAE Over The Counter (OTC) Pharmaceuticals Market, by Vitamins and Dietary Supplements, 2017-2022 (US$ Mn)
TABLE 14 UAE Over The Counter (OTC) Pharmaceuticals Market, by Vitamins and Dietary Supplements, 2023-2030 (US$ Mn)
TABLE 15 UAE Over The Counter (OTC) Pharmaceuticals Market, by Skin Care and Dermatological Products, 2017-2022 (US$ Mn)
TABLE 16 UAE Over The Counter (OTC) Pharmaceuticals Market, by Skin Care and Dermatological Products, 2023-2030 (US$ Mn)
TABLE 17 UAE Over The Counter (OTC) Pharmaceuticals Market, by Weight Loss and Nutritional Products, 2017-2022 (US$ Mn)
TABLE 18 UAE Over The Counter (OTC) Pharmaceuticals Market, by Weight Loss and Nutritional Products, 2023-2030 (US$ Mn)
TABLE 19 UAE Over The Counter (OTC) Pharmaceuticals Market, by Allergy Medications, 2017-2022 (US$ Mn)
TABLE 20 UAE Over The Counter (OTC) Pharmaceuticals Market, by Allergy Medications, 2023-2030 (US$ Mn)
TABLE 21 UAE Over The Counter (OTC) Pharmaceuticals Market, by Sleep Aids, 2017-2022 (US$ Mn)
TABLE 22 UAE Over The Counter (OTC) Pharmaceuticals Market, by Sleep Aids, 2023-2030 (US$ Mn)
TABLE 23 UAE Over The Counter (OTC) Pharmaceuticals Market, by Oral Care Products, 2017-2022 (US$ Mn)
TABLE 24 UAE Over The Counter (OTC) Pharmaceuticals Market, by Oral Care Products, 2023-2030 (US$ Mn)
TABLE 25 UAE Over The Counter (OTC) Pharmaceuticals Market, by Eye Care Products, 2017-2022 (US$ Mn)
TABLE 26 UAE Over The Counter (OTC) Pharmaceuticals Market, by Eye Care Products, 2023-2030 (US$ Mn)
TABLE 27 UAE Over The Counter (OTC) Pharmaceuticals Market, by Ear Care Products, 2017-2022 (US$ Mn)
TABLE 28 UAE Over The Counter (OTC) Pharmaceuticals Market, by Ear Care Products, 2023-2030 (US$ Mn)
TABLE 29 UAE Over The Counter (OTC) Pharmaceuticals Market, by First Aid Supplies, 2017-2022 (US$ Mn)
TABLE 30 UAE Over The Counter (OTC) Pharmaceuticals Market, by First Aid Supplies, 2023-2030 (US$ Mn)
TABLE 31 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pharmacies and Drugstores, 2017-2022 (US$ Mn)
TABLE 32 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pharmacies and Drugstores, 2023-2030 (US$ Mn)
TABLE 33 UAE Over The Counter (OTC) Pharmaceuticals Market, by Supermarkets and Hypermarkets, 2017-2022 (US$ Mn)
TABLE 34 UAE Over The Counter (OTC) Pharmaceuticals Market, by Supermarkets and Hypermarkets, 2023-2030 (US$ Mn)
TABLE 35 UAE Over The Counter (OTC) Pharmaceuticals Market, by Online Retail, 2017-2022 (US$ Mn)
TABLE 36 UAE Over The Counter (OTC) Pharmaceuticals Market, by Online Retail, 2023-2030 (US$ Mn)
TABLE 37 UAE Over The Counter (OTC) Pharmaceuticals Market, by Convenience Stores, 2017-2022 (US$ Mn)
TABLE 38 UAE Over The Counter (OTC) Pharmaceuticals Market, by Convenience Stores, 2023-2030 (US$ Mn)
TABLE 39 UAE Over The Counter (OTC) Pharmaceuticals Market, by Specialty Health Stores, 2017-2022 (US$ Mn)
TABLE 40 UAE Over The Counter (OTC) Pharmaceuticals Market, by Specialty Health Stores, 2023-2030 (US$ Mn)
TABLE 41 UAE Over The Counter (OTC) Pharmaceuticals Market, by Adults, 2017-2022 (US$ Mn)
TABLE 42 UAE Over The Counter (OTC) Pharmaceuticals Market, by Adults, 2023-2030 (US$ Mn)
TABLE 43 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pediatric OTC, 2017-2022 (US$ Mn)
TABLE 44 UAE Over The Counter (OTC) Pharmaceuticals Market, by Pediatric OTC, 2023-2030 (US$ Mn)
TABLE 45 UAE Over The Counter (OTC) Pharmaceuticals Market, by Geriatric OTC, 2017-2022 (US$ Mn)
TABLE 46 UAE Over The Counter (OTC) Pharmaceuticals Market, by Geriatric OTC, 2023-2030 (US$ Mn)
TABLE 47 UAE Over The Counter (OTC) Pharmaceuticals Market, by Sports and Fitness OTC, 2017-2022 (US$ Mn)
TABLE 48 UAE Over The Counter (OTC) Pharmaceuticals Market, by Sports and Fitness OTC, 2023-2030 (US$ Mn)
TABLE 49 UAE Over The Counter (OTC) Pharmaceuticals Market, by Product Categories, 2017-2022 (US$ Mn)
TABLE 50 UAE Over The Counter (OTC) Pharmaceuticals Market, by Product Categories, 2023-2030 (US$ Mn)
TABLE 51 UAE Over The Counter (OTC) Pharmaceuticals Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 52 UAE Over The Counter (OTC) Pharmaceuticals Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 53 UAE Over The Counter (OTC) Pharmaceuticals Market, by End Users, 2017-2022 (US$ Mn)
TABLE 54 UAE Over The Counter (OTC) Pharmaceuticals Market, by End Users, 2023-2030 (US$ Mn)

How big is the UAE market for over-the-counter (OTC) pharmaceuticals?

In 2022, the UAE over-the-counter (OTC) pharmaceutical market was estimated to be worth USD 0.61 million.

What is the UAE over-the-counter (OTC) pharmaceuticals market’s anticipated growth rate from 2023 to 2030?

The UAE over-the-counter (OTC) pharmaceuticals market is anticipated to increase at a CAGR of 4.60% from 2023 to 2030, reaching USD 0.87 million in 2030.

Which market category is in the lead for the product categories?

Cough and cold medications are the most popular category of product categories.

Which segment is leading the market in terms of distribution channels?

The notable segments are pharmacies and drugstores by distribution channels.

Which end-user segment is estimated to have the highest CAGR throughout the forecast period?

The pediatric OTC category is anticipated to exhibit the highest CAGR during the projection period.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –